The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Study finds common genetic target may halt breast cancer cell growth
2.
NIH research cuts leave cancer patient facing hard choice
3.
Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows
4.
When Should Immunocompromised Individuals Receive a COVID Booster?
5.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
1.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
2.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
3.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
4.
Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment
5.
Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation